Trial intelligence / Profile preview

Esketamine for tourniquet hypertension and postoperative recovery in lower extremity orthopedic surgery

ChiCTR2300072925Phase 4Not yet recruiting

Sponsor
Fuyang Hospital of Anhui Medical University
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in lower limb orthopedic disorders (2 arms), sponsored by Fuyang Hospital of Anhui Medical University. Primary endpoint: Incidence of intraoperative tourniquet hypertension. Planned start Jul 2023; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

lower limb orthopedic disorders

Beyond the preview

Go deeper on ChiCTR2300072925.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300072925.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call